Lead Generation and Optimization Based on Protein-Ligand Complementarity
暂无分享,去创建一个
[1] Marianne A Grant,et al. Protein structure prediction in structure-based ligand design and virtual screening. , 2009, Combinatorial chemistry & high throughput screening.
[2] Masilamani Elizabeth Sobhia,et al. Fingerprint Directed Scaffold Hopping for Identification of CCR2 Antagonists , 2008, J. Chem. Inf. Model..
[3] Aniko Simon,et al. eHiTS: a new fast, exhaustive flexible ligand docking system. , 2007, Journal of molecular graphics & modelling.
[4] Anna Linusson,et al. SHOP: scaffold HOPping by GRID-based similarity searches. , 2007, Journal of medicinal chemistry.
[5] Hiroshi Yamashita,et al. A Quantitative Approach to the Estimation of Chemical Space from a Given Geometry by the Combination of Atomic Species , 2007 .
[6] Massimo Baroni,et al. Virtual screening for novel openers of pancreatic K(ATP) channels. , 2007, Journal of medicinal chemistry.
[7] Gary Larson,et al. Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study. , 2007, Bioorganic & medicinal chemistry letters.
[8] Mohammed M. Abadleh,et al. From five- to six-membered rings: 3,4-diarylquinolinone as lead for novel p38MAP kinase inhibitors. , 2007, Journal of medicinal chemistry.
[9] Xiaoling Xie,et al. Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors. , 2007, Journal of medicinal chemistry.
[10] Hongyu Zhao,et al. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective. , 2007, Drug discovery today.
[11] G. Narahari Sastry,et al. Strategies to design pyrazolyl urea derivatives for p38 kinase inhibition: a molecular modeling study , 2007, J. Comput. Aided Mol. Des..
[12] Kazuto Yamazaki,et al. Identification of phosphodiesterase-1 and 5 dual inhibitors by a ligand-based virtual screening optimized for lead evolution. , 2006, Bioorganic & medicinal chemistry letters.
[13] G. Schneider,et al. Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.
[14] Peter Willett,et al. Scaffold Hopping Using Clique Detection Applied to Reduced Graphs , 2006, J. Chem. Inf. Model..
[15] Jonas Boström,et al. Computational chemistry-driven decision making in lead generation. , 2006, Drug discovery today.
[16] Ismael Zamora,et al. Virtual Screening and Scaffold Hopping Based on GRID Molecular Interaction Fields , 2005, J. Chem. Inf. Model..
[17] Jean-Pierre Gotteland,et al. Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase. , 2005, Journal of medicinal chemistry.
[18] J. Jenkins,et al. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.
[19] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[20] Philip M Dean,et al. Scaffold hopping in de novo design. Ligand generation in the absence of receptor information. , 2004, Journal of medicinal chemistry.
[21] Michelle Browner,et al. Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase. , 2003, Journal of medicinal chemistry.
[22] J. Lisnock,et al. The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity. , 2003, Chemistry & biology.
[23] Andreas Zell,et al. The Compressed Feature Matrix—a novel descriptor for adaptive similarity search , 2003, Journal of molecular modeling.
[24] G. Rishton. Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.
[25] Peter Willett,et al. Scaffold Searching: Automated Identification of Similar Ring Systems for the Design of Combinatorial Libraries , 2002 .
[26] Lars Naerum,et al. Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors. , 2002, Bioorganic & medicinal chemistry letters.
[27] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[28] R. Cramer,et al. Toward general methods of targeted library design: topomer shape similarity searching with diverse structures as queries. , 2000, Journal of medicinal chemistry.
[29] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[30] Schmid,et al. "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.
[31] J. Mason,et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.
[32] Frank T. Coppo,et al. Synthesis of 1-Methyl-7-(trifluoromethyl)-1H-pyrido[2,3-c][1,2]thiazin-4(3H)-one 2,2-Dioxide. , 1998 .
[33] P. Caron,et al. Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. , 1998, Structure.
[34] Frank T. Coppo,et al. Novel heterocycles. Synthesis of 2,3-dihydro-6-methyl-2-phenyl-4H,6H-pyrano[3,2-c][2,1]benzothiazin-4-one 5,5-dioxide and related compounds , 1998 .
[35] Eugene I. Shakhnovich,et al. SMOG : DE NOVO DESIGN METHOD BASED ON SIMPLE, FAST, AND ACCURATE FREE ENERGY ESTIMATES. 2. CASE STUDIES IN MOLECULAR DESIGN , 1997 .
[36] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[37] D K Gehlhaar,et al. De novo design of enzyme inhibitors by Monte Carlo ligand generation. , 1995, Journal of medicinal chemistry.
[38] P Willett,et al. Docking small-molecule ligands into active sites. , 1995, Current opinion in biotechnology.
[39] Daniel A. Gschwend,et al. Orientational sampling and rigid‐body minimization in molecular docking , 1993, Proteins.
[40] A Itai,et al. Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation. , 1993, Journal of medicinal chemistry.
[41] Hans-Joachim Böhm,et al. LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads , 1992, J. Comput. Aided Mol. Des..
[42] W L Jorgensen,et al. Rusting of the lock and key model for protein-ligand binding. , 1991, Science.
[43] H. Scheraga,et al. Accessible surface areas as a measure of the thermodynamic parameters of hydration of peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[44] G. Coppola,et al. Novel heterocycles. 4. Synthesis of the pyrido[2,3-c]-1,2-thiazine ring system , 1979 .
[45] J. Lombardino. Preparation of some 4‐hydroxyl‐1‐methyl‐1H‐2,1‐benzothiazine‐3‐carboxanilide 2,2‐dioxides , 1972 .